or Try an Advanced Search...

    Technical Analysis for AZTR - Azitra Inc.

    Grade Last Price % Change Price Change
    F 0.18 0.11% 0.00
    AZTR closed up 0.11 percent on Wednesday, May 15, 2024, on 84 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical AZTR trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish 0.11%
    Calm After Storm Range Contraction 0.11%
    NR7 Range Contraction 0.11%
    Older End-of-Day Signals for AZTR ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 12 hours ago
    Possible Inside Day about 12 hours ago
    1.5x Volume Pace about 15 hours ago
    Up 3% about 16 hours ago
    Up 2% about 16 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AZTR Chart by TradingView
    Basic chart:

    Profile

    Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Rare Diseases Molecular Biology Epidermal Growth Factor Receptor Genodermatoses Skin Diseases Netherton Syndrome Pre Clinical Biopharmaceutical Biotherapeutic Products Ichthyosis

    Is AZTR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 Azitra GAAP EPS of -$0.15
    May 10 Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
    May 9 Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates
    May 5 Wall Street Breakfast: The Week Ahead
    Apr 22 Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
    Apr 18 Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
    Apr 2 Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
    Mar 15 Azitra GAAP EPS of -$1.83, revenue of $0.69M
    Mar 15 Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates
    Feb 16 Azitra, Inc. Announces Closing of Public Offering
    See more AZTR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.18
    52 Week Low 0.1605
    Average Volume 763,132
    200-Day Moving Average 1.18
    50-Day Moving Average 0.22
    20-Day Moving Average 0.22
    10-Day Moving Average 0.22
    Average True Range 0.03
    RSI (14) 34.64
    ADX 19.61
    +DI 17.61
    -DI 24.20
    Chandelier Exit (Long, 3 ATRs) 0.20
    Chandelier Exit (Short, 3 ATRs) 0.26
    Upper Bollinger Bands 0.27
    Lower Bollinger Band 0.17
    Percent B (%b) 0.09
    BandWidth 47.33
    MACD Line -0.01
    MACD Signal Line -0.01
    MACD Histogram -0.0032
    Fundamentals Value
    Market Cap 2.13 Million
    Num Shares 12.1 Million
    EPS -1.23
    Price-to-Earnings (P/E) Ratio -0.14
    Price-to-Sales 22.01
    Price-to-Book 2.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.19
    Resistance 3 (R3) 0.19 0.19 0.19
    Resistance 2 (R2) 0.19 0.18 0.19 0.19
    Resistance 1 (R1) 0.18 0.18 0.18 0.18 0.18
    Pivot Point 0.18 0.18 0.18 0.18 0.18
    Support 1 (S1) 0.17 0.18 0.17 0.17 0.17
    Support 2 (S2) 0.17 0.17 0.17 0.17
    Support 3 (S3) 0.17 0.17 0.17
    Support 4 (S4) 0.16